2021
NAFLD: a multi-faceted morbid spectrum with uncertain diagnosis and complicated management.
DI Renzo C, Vitale A, D'Amico F, Cillo U. NAFLD: a multi-faceted morbid spectrum with uncertain diagnosis and complicated management. Minerva Surgery 2021, 76: 450-466. PMID: 33855376, DOI: 10.23736/s2724-5691.21.08729-0.Peer-Reviewed Original ResearchConceptsNon-alcoholic fatty liver diseaseNon-alcoholic steatohepatitisNon-alcoholic steatohepatitis cirrhosisNon-alcoholic steatohepatitis patientsDegree of suspicionPost-transplant managementFatty liver diseasePatient related issuesLiver transplantationLiver diseaseEarly diagnosisMetabolic dysfunctionMorbidity spectrumComplication managementDiagnostic testsDiagnosisMetabolic issuesPatients
2007
Cross-talk between PDGF and S1P signalling elucidates the inhibitory effect and potential antifibrotic action of the immunomodulator FTY720 in activated HSC-cultures
Brunati A, Tibaldi E, Carraro A, Gringeri E, D’Amico F, Toninello A, Massimino M, Pagano M, Nalesso G, Cillo U. Cross-talk between PDGF and S1P signalling elucidates the inhibitory effect and potential antifibrotic action of the immunomodulator FTY720 in activated HSC-cultures. Biochimica Et Biophysica Acta 2007, 1783: 347-359. PMID: 18157950, DOI: 10.1016/j.bbamcr.2007.11.008.Peer-Reviewed Original ResearchConceptsPlatelet-derived growth factorHepatic stellate cellsTyrosine phosphorylation of PDGF receptorsSignaling pathwayPlatelet-derived growth factor stimulationCross-talkPlatelet-derived growth factor signaling pathwaysPhosphorylation of PDGF receptorS1P signalingStimulation of chemotaxisPlasma membranePhosphorylated formSphingosine-1-phosphateEffect of FTY720Activation of hepatic stellate cellsReceptor-independent wayFTY720 phosphorylationDevelopment of hepatic fibrosisS1P signaling pathwayPDGF receptorsCell typesCell proliferationPhosphorylationAntifibrotic actionMechanism of action